메뉴 건너뛰기




Volumn 21, Issue 1, 2011, Pages 117-118

Ustekinumab for the treatment of an adolescent patient with recalcitrant plaque psoriasis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; BETAMETHASONE PROPIONATE PLUS CALCIPOTRIOL; CYCLOSPORIN; ETANERCEPT; TACROLIMUS; UNCLASSIFIED DRUG; USTEKINUMAB; MONOCLONAL ANTIBODY;

EID: 79957503027     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1177     Document Type: Letter
Times cited : (23)

References (6)
  • 1
    • 0033946247 scopus 로고    scopus 로고
    • A comparative study of pediatric onset psoriasis with adult onset psoriasis
    • Raychaudhuri SP, Gross J. A comparative study of pediatric onset psoriasis with adult onset psoriasis. Pediatr Dermatol 2000; 60: 174-8.
    • (2000) Pediatr Dermatol , vol.60 , pp. 174-178
    • Raychaudhuri, S.P.1    Gross, J.2
  • 2
    • 70350497587 scopus 로고    scopus 로고
    • Therapies for childhood psoriasis
    • Trueb RM. Therapies for childhood psoriasis. Curr Probl Dermatol 2009; 38: 137-59.
    • (2009) Curr Probl Dermatol , vol.38 , pp. 137-159
    • Trueb, R.M.1
  • 4
    • 77952807155 scopus 로고    scopus 로고
    • Efficacy and safety of etanercept in children and adolescents aged >/= 8 years with severe plaque psoriasis
    • Landells I, Paller AS, Pariser D, et al. Efficacy and safety of etanercept in children and adolescents aged >/= 8 years with severe plaque psoriasis. Eur J Dermatol 2010; 20: 323-8.
    • (2010) Eur J Dermatol , vol.20 , pp. 323-328
    • Landells, I.1    Paller, A.S.2    Pariser, D.3
  • 5
    • 43449111187 scopus 로고    scopus 로고
    • Efficacy and safety of ustekinumab, a human inteleukin-12/23 monoclonal antibody, in patients with psoriasis: A 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX I)
    • Leonardi CL, Kimball AB, Papp KA, et al. Efficacy and safety of ustekinumab, a human inteleukin-12/23 monoclonal antibody, in patients with psoriasis: a 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX I). Lancet 2008; 371: 1665-74.
    • (2008) Lancet , vol.371 , pp. 1665-1674
    • Leonardi, C.L.1    Kimball, A.B.2    Papp, K.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.